Cargando…
Evaluation of a lateral-flow nanoparticle fluorescence assay for TB infection diagnosis
BACKGROUND: Programmatic management of TB infection is a critical component of the WHO End TB Strategy. Interferon-gamma release assays (IGRAs) overcome some limitations of the tuberculin skin test, but implementation of IGRA testing in low-resource settings is challenging. METHODS: In this feasibil...
Autores principales: | Stieber, F., Howard, J., Manissero, D., Boyle, J., Ndunda, N., Love, J., Yang, M., Schumacher, A., Uchiyama, R., Parsons, S., Miller, C., Douwes, H., Mielens, Z., Laing, T., Nikolayevskyy, V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union Against Tuberculosis and Lung Disease
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544925/ https://www.ncbi.nlm.nih.gov/pubmed/34686234 http://dx.doi.org/10.5588/ijtld.21.0391 |
Ejemplares similares
-
First performance report of QIAreach™ Anti-SARS-CoV-2 Total Test, an innovative nanoparticle fluorescence digital detection platform
por: Stieber, Francis, et al.
Publicado: (2020) -
Accuracy of interferon gamma release assays for the COVID-19 immunity assessment
por: Stieber, Francis, et al.
Publicado: (2022) -
Durability of COVID-19 vaccine induced T-cell mediated immune responses measured using the QuantiFERON SARS-CoV-2 assay
por: Stieber, F., et al.
Publicado: (2023) -
Preliminary Evaluation of QuantiFERON SARS-CoV-2 and QIAreach Anti-SARS-CoV-2 Total Test in Recently Vaccinated Individuals
por: Jaganathan, Soumya, et al.
Publicado: (2021) -
The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses
por: Goletti, Delia, et al.
Publicado: (2021)